 Ellis Investment Partners LLC purchased a new stake in Arena Pharmaceuticals, Inc. NASDAQ:ARNA in the second quarter, according to the company in its most recent filing with the Securities Exchange Commission. The firm purchased 1,250 shares of the biopharmaceutical companys stock, valued at approximately 78,000. A number of other hedge funds have also recently ... 